Trends in atrial fibrillation ablation: have we maximized the current paradigms?

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 3396333)

Published in J Interv Card Electrophysiol on February 28, 2012

Authors

Roger A Winkle1, R Hardwin Mead, Gregory Engel, Melissa H Kong, Rob A Patrawala

Author Affiliations

1: Silicon Valley Cardiology, 1950 University Avenue, Suite 160, East Palo Alto, CA 94303, USA. rawinkle@aol.com

Articles cited by this

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med (1998) 23.22

A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol (2004) 7.26

HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm (2007) 7.20

Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol (2011) 4.12

Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm (2009) 2.30

Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol (2009) 2.19

Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation (2003) 2.17

Long-term single procedure efficacy of catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2006) 2.05

Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm (2009) 2.02

The use of dabigatran immediately after atrial fibrillation ablation. J Cardiovasc Electrophysiol (2011) 1.97

Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm (2011) 1.93

Mechanisms of recurrent atrial fibrillation after pulmonary vein isolation by segmental ostial ablation. Heart Rhythm (2004) 1.89

General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: results from a randomized study. Heart Rhythm (2010) 1.79

The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm (2011) 1.73

Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study. Heart Rhythm (2010) 1.45

Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol (2008) 1.35

Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.30

Robotic navigation in catheter ablation for paroxysmal atrial fibrillation: midterm efficacy and predictors of postablation arrhythmia recurrences. J Cardiovasc Electrophysiol (2010) 1.22

Is pulmonary vein isolation necessary for curing atrial fibrillation? Circulation (2003) 1.15

Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation. Europace (2012) 1.13

Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. J Cardiovasc Electrophysiol (2010) 1.12

Remote magnetic navigation with irrigated tip catheter for ablation of paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.11

Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm (2009) 1.09

Long-term results of atrial fibrillation ablation: the importance of all initial ablation failures undergoing a repeat ablation. Am Heart J (2011) 1.08

Epicardial ablation of rotors suppresses inducibility of acetylcholine-induced atrial fibrillation in left pulmonary vein-left atrium preparations in a beagle heart failure model. J Am Coll Cardiol (2011) 1.03

Safety of lower activated clotting times during atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture. Am J Cardiol (2010) 0.98

Long-term follow-up after radiofrequency catheter ablation for atrial fibrillation. Europace (2008) 0.96

Predictors of success after selective pulmonary vein isolation of arrhythmogenic pulmonary veins for treatment of atrial fibrillation. Heart Rhythm (2006) 0.95

Gender-related differences in catheter ablation of atrial fibrillation. Europace (2007) 0.93

Atrial fibrillation ablation: "perpetual motion" of open irrigated tip catheters at 50 W is safe and improves outcomes. Pacing Clin Electrophysiol (2011) 0.91

Relation of early termination of persistent atrial fibrillation by cardioversion or drugs to ablation outcomes. Am J Cardiol (2011) 0.81

Catheter ablation of atrial fibrillation: do we know what we are doing? Europace (2007) 0.79

Articles by these authors

The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol (2011) 2.51

Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin Electrophysiol (2004) 2.38

Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol (2009) 2.19

The use of dabigatran immediately after atrial fibrillation ablation. J Cardiovasc Electrophysiol (2011) 1.97

The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm (2011) 1.73

Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Am Heart J (2011) 1.72

Novel predictor of prognosis from exercise stress testing: heart rate variability response to the exercise treadmill test. Am Heart J (2007) 1.53

Chronic performance of an active fixation coronary sinus lead. Heart Rhythm (2010) 1.42

Early human experience with use of a deflectable fiberoptic endocardial visualization catheter to facilitate coronary sinus cannulation. Heart Rhythm (2006) 1.41

Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients. Europace (2013) 1.40

Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation. Europace (2012) 1.13

Long-term results of atrial fibrillation ablation: the importance of all initial ablation failures undergoing a repeat ablation. Am Heart J (2011) 1.08

The prognostic value of T wave amplitude in lead aVR in males. Ann Noninvasive Electrocardiol (2008) 1.03

Electrocardiographic damage scores and cardiovascular mortality. Am Heart J (2005) 1.00

Genetic characterization of rhesus macaques (Macaca mulatta) in Nepal. Am J Primatol (2006) 0.99

Early clinical experience with networked system for promoting patient self-management. Am J Manag Care (2011) 0.99

Safety of lower activated clotting times during atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture. Am J Cardiol (2010) 0.98

Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation. J Interv Card Electrophysiol (2013) 0.93

Atrial fibrillation ablation: "perpetual motion" of open irrigated tip catheters at 50 W is safe and improves outcomes. Pacing Clin Electrophysiol (2011) 0.91

Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: the Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study. Am Heart J (2008) 0.88

New World simian foamy virus infections in vivo and in vitro. J Virol (2013) 0.84

Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age. Am Heart J (2010) 0.84

Characterization of human coronary sinus valves by direct visualization during biventricular pacemaker implantation. Pacing Clin Electrophysiol (2008) 0.83

Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes. J Interv Card Electrophysiol (2013) 0.82

Relation of early termination of persistent atrial fibrillation by cardioversion or drugs to ablation outcomes. Am J Cardiol (2011) 0.81

Characterizing the threat to the blood supply associated with nonoccupational exposure to emerging simian retroviruses. Transfusion (2007) 0.79

Peri-ablation warfarin vs. dabigatran: different but the same. Europace (2013) 0.79

Computerized QT dispersion measurement and cardiovascular mortality in male veterans. Am J Cardiol (2004) 0.79

Atrial arrhythmia burden on long-term monitoring in asymptomatic patients late after atrial fibrillation ablation. Am J Cardiol (2012) 0.78

Survey of Treponemal Infections in Free-Ranging and Captive Macaques, 1999-2012. Emerg Infect Dis (2017) 0.76

Remote monitoring for atrial fibrillation. Congest Heart Fail (2009) 0.76

Safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing ablation for atrial fibrillation. J Am Coll Cardiol (2012) 0.76

Laser lead extraction in congenital heart disease: a case-controlled study. Pacing Clin Electrophysiol (2013) 0.76

Responses to abortion training. Fam Med (2008) 0.75

Pediculosis in Macaca sylvanus of Gibraltar. Vet Parasitol (2007) 0.75

Dobutamine stress echocardiography in preoperative and long-term postoperative risk assessment of elderly patients. Am J Geriatr Cardiol (2003) 0.75

Premature ventricular contractions causing pacemaker-mediated tachycardia: a failure of postventricular atrial refractory period after premature ventricular contraction extension? Heart Rhythm (2005) 0.75